Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors. Eur. Pharmacol. 537: 31-6

P Van Antwerpen, I Legssyer, K Zouaoui Boudjeltia, S Babar, P Moreau, Nicole Moguilevsky, M Vanhaeverbeek, J Ducobu, J Nève

    Research output: Contribution to journalArticle

    Original languageEnglish
    Pages (from-to)31-36
    Number of pages6
    JournalEuropean Journal of Pharmacology
    Issue number1-3
    Publication statusPublished - 2006

    Cite this